conbercept eye drop (KH906) / Chengdu Kanghong Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
conbercept eye drop (KH906) / Chengdu Kanghong Pharma
NCT04215393: An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of KH906 in Patients With Corneal Neovascularization

Unknown status
1
39
RoW
Conbercept eye drop, Placebo
Chengdu Kanghong Biotech Co., Ltd.
Corneal Neovascularization
04/20
12/20

Download Options